Reflections on Novel Targets and Emerging Regimens for RCC

Arnab Basu, MD, MPH, FACP, weighs in on novel therapeutic targets and emerging regimens that may further improve kidney cancer outcomes.

Related Videos
Andre H. Goy, MD, an expert on B-cell malignancies
Andrew Ip, MD, an expert on B-cell malignancies
Andrew Ip, MD, an expert on B-cell malignancies
Andrew Ip, MD, an expert on B-cell malignancies
Andrew Ip, MD, an expert on diffuse large B-cell lymphoma
Andre Goy, MD, an expert on mantle cell lymphoma
André Goy, MD, an expert on B-cell malignancies
André Goy, MD, an expert on B-cell malignancies
Expert on endometrial cancer
André Goy, MD, an expert on B-cell malignancies
Related Content